Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Novozymes North America, Inc. v. Danisco US Inc., No. 21-2184 (Fed. Cir. Oct. 5, 2022)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 21-2184
Decided
October 5, 2022
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit NOVOZYMES NORTH AMERICA, INC.,

Appellant

v.

DANISCO US INC.,

Appellee

2021-2184

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2020-00464.

JUDGMENT

JEFFREY PAUL KUSHAN, Sidley Austin LLP, Washington, DC, argued for appellant. Also represented by LAUREN CRANFORD KATZEFF, JOSHUA JOHN FOUGERE; SONA DE, New York, NY. PIER DEROO, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for appellee. Also represented by MICHAEL J. FLIBBERT.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

October 5, 2022 /s/ Peter R. Marksteiner

Date Peter R. Marksteiner

Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Novozymes North America, Inc. v. Danisco US Inc., No. 21-2184 (Fed. Cir. Oct. 5, 2022).

Record ID
CAFC-21-2184-20221005
Permalink
https://patentcasewatch.com/opinions/CAFC-21-2184-20221005

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.